News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,214 Results
Type
Article (14240)
Company Profile (282)
Press Release (252692)
Section
Business (79600)
Career Advice (153)
Deals (13252)
Drug Delivery (35)
Drug Development (50458)
Employer Resources (31)
FDA (5721)
Job Trends (5149)
News (144545)
Policy (10039)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (924)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21662)
ALS (61)
Alzheimer's disease (837)
Antibody-drug conjugate (ADC) (88)
Approvals (5739)
Artificial intelligence (112)
Autoimmune disease (13)
Automation (5)
Bankruptcy (104)
Best Places to Work (4579)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (20)
Breast cancer (142)
Cancer (1318)
Cardiovascular disease (112)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (308)
Cervical cancer (8)
Clinical research (40924)
Collaboration (500)
Compensation (228)
Complete response letters (13)
COVID-19 (1034)
CRISPR (37)
C-suite (146)
Cystic fibrosis (76)
Data (1385)
Denatured (11)
Depression (29)
Diabetes (126)
Diagnostics (1303)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (79)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (29715)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48248)
Executive appointments (410)
FDA (6353)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (471)
Gene editing (90)
Generative AI (9)
Gene therapy (234)
GLP-1 (358)
Government (1075)
Grass and pollen (2)
Guidances (18)
Healthcare (6626)
Huntington's disease (21)
IgA nephropathy (22)
Immunology and inflammation (80)
Indications (18)
Infectious disease (1096)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (58)
Interviews (17)
IPO (7280)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (203)
Leadership (2)
Legal (1392)
Liver cancer (30)
Lung cancer (187)
Lymphoma (84)
Machine learning (1)
Management (7)
Manufacturing (116)
MASH (49)
Medical device (2603)
Medtech (2604)
Mergers & acquisitions (6269)
Metabolic disorders (366)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (61)
Neuropsychiatric disorders (23)
Neuroscience (1215)
NextGen: Class of 2025 (2035)
Non-profit (929)
Northern California (1575)
Now hiring (21)
Obesity (186)
Opinion (100)
Ovarian cancer (60)
Pain (41)
Pancreatic cancer (51)
Parkinson's disease (111)
Partnered (8)
Patents (112)
Patient recruitment (68)
Peanut (35)
People (25547)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14448)
Phase II (19037)
Phase III (12042)
Pipeline (744)
Podcasts (47)
Policy (38)
Postmarket research (854)
Preclinical (6071)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (277)
Real estate (1423)
Recruiting (12)
Regulatory (8580)
Reports (15)
Research institute (940)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (56)
Series A (92)
Series B (60)
Service/supplier (1)
Sickle cell disease (39)
Southern California (1394)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1973)
State (1)
Stomach cancer (4)
Supply chain (18)
Tariffs (3)
The Weekly (35)
United States (12280)
Vaccines (205)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (68)
Last 7 days (406)
Last 30 days (1605)
Last 365 days (20001)
2025 (4951)
2024 (20569)
2023 (22430)
2022 (26851)
2021 (27836)
2020 (23391)
2019 (16331)
2018 (11781)
2017 (13756)
2016 (11859)
2015 (14364)
2014 (10401)
2013 (7495)
2012 (7540)
2011 (7620)
2010 (7440)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17244)
Australia (2921)
California (3571)
Canada (1067)
China (326)
Colorado (138)
Connecticut (143)
Delaware (88)
Europe (37090)
Florida (423)
Georgia (110)
Idaho (16)
Illinois (214)
India (9)
Indiana (87)
Iowa (1)
Japan (71)
Kansas (60)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (446)
Massachusetts (2820)
Michigan (69)
Minnesota (138)
Mississippi (1)
Missouri (23)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (893)
New Mexico (12)
New York (968)
North Carolina (525)
North Dakota (4)
Northern California (1575)
Ohio (108)
Oklahoma (9)
Oregon (21)
Pennsylvania (680)
Puerto Rico (4)
Rhode Island (15)
South America (208)
South Carolina (4)
Southern California (1394)
Tennessee (25)
Texas (412)
Utah (48)
Virginia (70)
Washington D.C. (28)
Washington State (324)
Wisconsin (13)
267,214 Results for "fountain therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.
January 2, 2025
·
6 min read
Pharm Country
The fountain of youth is … a T cell?
The fountain of youth has eluded explorers for ages. It turns out the magic anti-aging elixir might have been inside us all along.
January 24, 2024
·
2 min read
Pharm Country
Bloomage Biotech receives the PCHi2023 Fountain Awards for innovation exellence
Bloomage Biotech has been awarded the prestigious Fountain Awards at the Asia-Pacific international event, PCHi, held in Guangzhou from February 15th to 17th, 2023.
March 6, 2023
·
2 min read
Hemostemix’ “Your Fountain of Youth” Trademark Granted by Switzerland
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce its Trademark, Your Fountain of Youth, was granted protection in Switzerland by its Trademark Office.
January 30, 2023
·
5 min read
Biotech Bay
Fountain Therapeutics Congratulates Co-Founder and Executive Chairman Thomas Rando, M.D., Ph.D., for Prestigious NOMIS Distinguished Scientist Award
Fountain Therapeutics announced that Thomas Rando, M.D., Ph.D., co-founder and executive chairman of Fountain, is being honored in a ceremony held in Zurich to receive the prestigious NOMIS Distinguished Scientist Award.
October 5, 2022
·
4 min read
Investors Fuel Fountain of Youth Research with Longevity Company Funding
The call to develop therapeutics that interfere with aging, helping people live longer, healthier lives, is increasing—and experts say the market opportunity is high.
October 3, 2023
·
5 min read
·
Kate Goodwin
Hemostemix’ “Your Fountain of Youth” Trademark Granted by Japan Patent Office
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the Japan Patent Office issued Kwalata Trading Limited, a wholly owned subsidiary of Hemostemix Inc., a trademark registration certificate for Your Fountain of Youth.
January 26, 2023
·
5 min read
Hemostemix Issued ‘Your Fountain of Youth’ Trademark by Cyprus
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the Office of the Registrar of Trademarks, Republic of Cyprus, issued Kwalata Trading Limited, a wholly owned subsidiary of Hemostemix Inc., a trademark registration certificate for Your Fountain of Youth.
December 8, 2022
·
5 min read
Business
Fountain Therapeutics Announces Appointment of Anupama Hoey as Chief Business Officer
Fountain Therapeutics today announced the appointment of Anupama Hoey as chief business officer (CBO) effective January 17 th , 2022.
January 18, 2022
·
3 min read
Biotech Bay
Fountain Therapeutics Announces $15 Million Series A-2 Financing
Fountain Therapeutics today announced a $15 million Series A-2 financing, which brings its total Series A funding to $26 million.
November 18, 2021
·
3 min read
1 of 26,722
Next
